Nexalin Technology NXL
NASDAQ NXL
$4.87 -0.18 (-3.56%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Change in Acquisitions & Divestments (2023 - 2026)

Nexalin Technology (NXL) posted Change in Acquisitions & Divestments of $5.6 million for Q1 2026, down 41.03% on a QoQ basis from $9.5 million in Q4 2025, and down 13.95% year-over-year from $6.5 million in Q1 2025.

Analysis

Nexalin Technology (NXL) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends

Nexalin Technology has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $5.6 million in Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 13.95% year-over-year to $5.6 million in Q1 2026; TTM through Mar 2026 was $39.8 million, a 18.91% increase from a year earlier, with the FY2025 full-year figure at $40.7 million, up 22.58% from the prior year.
  • Change in Acquisitions & Divestments was $5.6 million for Q1 2026 at Nexalin Technology, down from $9.5 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $13.5 million in Q3 2025, with the low at $2.9 million in Q2 2024.
  • Average Change in Acquisitions & Divestments over 4 years is $9.3 million, with a median of $9.6 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments sank 69.29% in 2024, then surged 281.83% in 2025.
  • Over 4 years, Change in Acquisitions & Divestments stood at $8.6 million in 2023, then advanced by 26.36% to $10.9 million in 2024, then fell by 12.85% to $9.5 million in 2025, then sank by 41.03% to $5.6 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $5.6 million (Q1 2026), $9.5 million (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Nexalin Technology 3.44 Mn 2.44 Mn 8,897.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 5.59 Mn
Dec 31, 2025 9.48 Mn
Sep 30, 2025 13.55 Mn
Jun 30, 2025 11.21 Mn
Mar 31, 2025 6.50 Mn
Dec 31, 2024 10.88 Mn
Sep 30, 2024 13.18 Mn
Jun 30, 2024 2.93 Mn
Mar 31, 2024 6.24 Mn
Dec 31, 2023 8.61 Mn
Sep 30, 2023 11.52 Mn
Jun 30, 2023 9.56 Mn
Mar 31, 2023 11.60 Mn